Login / Signup

BART-D2 subtype of EBV encoded BART miRNA cluster 1 region is strongly associated with endemic nasopharyngeal carcinoma.

Qiaoyi WangHuijing HeXinqiang JiYang LiuHaoyan LiYun Wang
Published in: Journal of medical virology (2023)
Epstein-Barr virus (EBV)-encoded BamHI A rightward transcript (BART) microRNAs (miRNAs) play important roles in viral infection and tumorigenesis. The association of sequence variations in the BART miRNA cluster 1 region with diseases remains unclear. Herein, 6 types and 11 subtypes of BART cluster 1 were identified in 354 tumors and healthy donors (HDs) from nasopharyngeal carcinoma (NPC)-endemic and non-endemic China (genotyped data), and 905 EBV genomes retrieved from GenBank from diseased and normal people from around the world (archived data). The distributions of BART cluster 1 types/subtypes between NPC-endemic and non-endemic China; between Asian regions and Africa/Europe & Australia & USA; and among Asian regions (NPC-endemic China, NPC-non-endemic East Asia and Southeast Asia) were significantly different (P<0.001). The subtype BART-D2 was not found outside Asia and was only common in NPC-endemic China. More importantly, BART-D2 had a higher frequency in NPCs than in HDs in NPC-endemic China (genotyped data, 78.0% vs. 44.1%, P<0.001; achieved data, 89.3% vs. 43.7%, P<0.001), and was also more frequent in NPCs than in HDs, gastric carcinomas, and lymphomas in NPC-non-endemic China (genotyped data, 27.9% vs. 1.9%, 2.4%, and 0.0%, P<0.001). BART-D2 was preferentially linked with the high-risk subtypes for NPC previously reported, 162476C or 163364T, in the BALF2 gene, and was associated with NPC risk (P<0.01). In vitro experiments showed that BART-D2 affected the expression of some mature BART miRNAs. These findings demonstrate geographically restricted variations of BART cluster 1 and identify distinct subtype that is confined to NPC-endemic China and is associated with NPC. This article is protected by copyright. All rights reserved.
Keyphrases
  • epstein barr virus
  • electronic health record
  • diffuse large b cell lymphoma
  • big data
  • poor prognosis
  • artificial intelligence
  • binding protein
  • deep learning